(Q28218040)

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-005-0038-9

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

12 December 2020

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

1 reference

12 December 2020

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

12 December 2020

Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

12 December 2020

Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans

1 reference

12 December 2020

Novel risk factors for atherosclerosis

1 reference

12 December 2020

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

12 December 2020

The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction

1 reference

12 December 2020

Leucocyte-endothelial interactions and regulation of leucocyte migration.

1 reference

12 December 2020

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

12 December 2020

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

1 reference

12 December 2020

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

1 reference

12 December 2020

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

12 December 2020

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

1 reference

12 December 2020

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis

1 reference

12 December 2020

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

12 December 2020

Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group

1 reference

12 December 2020

The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall

1 reference

12 December 2020

Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects.

1 reference

12 December 2020

Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia

1 reference

12 December 2020

The changing pattern of cardiovascular diseases in China

1 reference

12 December 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

12 December 2020

Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study.

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

1 reference

12 December 2020

Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease

1 reference

12 December 2020

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

1 reference

12 December 2020

Oxidative modification of lipoprotein(a) and the effect of beta-carotene

1 reference

12 December 2020

Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study

1 reference

12 December 2020

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

12 December 2020

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

1 reference

12 December 2020

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

1 reference

12 December 2020

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

12 December 2020

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)

1 reference

12 December 2020

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

1 reference

12 December 2020

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

12 December 2020

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

1 reference

12 December 2020

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

1 reference

12 December 2020

Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases

1 reference

12 December 2020